Skip to content

Bilateral differential frequency in subthalamic nucleus deep brain stimulation for Parkinson disease

Bilateral differential frequency in subthalamic nuclues deep brain stimulation for Parkinson disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016522
Enrollment
Unknown
Registered
2018-06-06
Start date
2018-05-12
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parkinson disease

Interventions

A:after activation of the implantable pulse generator,bilateral stimulation frequencies are set divergently(More than 30Hz difference) for 3 months,then set at the same level(same frequency number) f
B:after activation of the implantable pulse generator,bilateral stimulation frequencies are set at the same level(same frequency number) for 3 months,then set at divergently(More than 30Hz difference)

Sponsors

Neurosuegery Department, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Idiopathic Parkinsons disease, in according with 2016 China diagnostic criteria for Parkinson's disease; 2. Levodopa Responsiveness improvement rate more than 30%; 3. Aged between 18-65 years old; 4. Medical Treatment is ineffective, even by further adjustment of therapeutic schedule; 5. Medical Treatment is effective, but patients can't bear the side effect within that dose (for example, severely disabling involuntary movement); 6. Dysfunction not responsive to medical treatment severely interferes with daily life; 7. patient or statutory guardian signs informed consent, with good compliance and cooperation with the follow-up.

Exclusion criteria

Exclusion criteria: 1. obviously affective disorder or phrenoblabia; 2. nervous system disease, such as epilepsy, brain trauma,brain tumor, severe cerebral infarction, alzheimer's disease, etc.; 3. people forbidden to MRI scan , for example with metal implantation materials; 4. All surgical contraindications (anticoagulants,terminal cancer, infectious disease and immuno-deficiency, etc.); 5. Pregnant or lactating women; 6. serve cognition impairment,incapable of cooperating with surgery and follow up; 7. Any situation endangering patient and it's successfully participation of the research program.

Design outcomes

Primary

MeasureTime frame
Unified Pakinson's Disease Rating Scale part II and III;Montreal cognitive assessment;Hamilto Anxiety;Hamilton Depression Scale;Unified Dyskinesia Rating Scale (UDysRS);

Secondary

MeasureTime frame
39-Item Parkinson's Disease Questionnaire;Minimum Mental State Examination;

Countries

China

Contacts

Public ContactWang Wei

Neurosuegery Department, West China Hospital, Sichuan University

13808170699@126.com+86 18982078332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026